Skip to main content
BrainCited

説明

Supplementary information from the review of curcumin formulations and clinical trials in neurological diseases.

Figure 5

Source Paper

Curcumin Formulations and Trials: What's New in Neurological Diseases.

Molecules (Basel, Switzerland) (2020)

PMID: 33217959

DOI: 10.3390/molecules25225389

Cite This Figure

![Figure 5: Supplementary information from the review of curcumin formulations and clinical trials in neurological diseases.]()

> Source: Stella Gagliardi et al. "Curcumin Formulations and Trials: What's New in Neurological Diseases.." *Molecules (Basel, Switzerland)*, 2020. PMID: [33217959](https://pubmed.ncbi.nlm.nih.gov/33217959/)
<figure>
  <img src="" alt="Supplementary information from the review of curcumin formulations and clinical trials in neurological diseases." />
  <figcaption>Figure 5. Supplementary information from the review of curcumin formulations and clinical trials in neurological diseases.<br>  Source: Stella Gagliardi et al. "Curcumin Formulations and Trials: What's New in Neurological Diseases.." <em>Molecules (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33217959/">33217959</a></figcaption>
</figure>